Long-Term Safety and Performance of BioMime™ Morph Sirolimus-Eluting Coronary Stent System for Very Long Coronary Lesions.

Published in: Cardiology research (2024)

BioMime™ Morph SES showed favorable outcomes up to 3 years in treating very long coronary lesions in native coronary arteries, as demonstrated by an acceptable rate of MACEs and absence of ST, based on clinical outcomes up to 3 years.

Keyphrases

coronary artery disease
coronary artery
aortic stenosis
type diabetes
heart failure
adipose tissue
metabolic syndrome
transcatheter aortic valve replacement
aortic valve
ejection fraction
glycemic control